I

106TH CONGRESS

2D SESSION H. R. 5427

To reauthorize the Drug-Free Communities Act, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

OCTOBER 10, 2000

Mr. PORTMAN (for himself and Mr. LEVIN) introduced the following bill;

which was referred to the Committee on Government Reform, and in addition to the Committee on Commerce, for a period to be subsequently

determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To reauthorize the Drug-Free Communities Act, and for

other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DRUG-FREE COMMUNITIES SUPPORT PRO4 GRAM.

5 (a) SHORT TITLE.—Chapter 2 of the National Nar6 cotics Leadership Act of 1988 (21 U.S.C. 1521 et seq.),

7 (referred to in this section as ‘‘the Act’’) is amended by

8 inserting after the chapter heading the following:
2

•HR 5427 IH

1 ‘‘SEC. 1020. SHORT TITLE.

2 ‘‘This chapter may be cited as the ‘Drug-Free Com3 munities Act’.’’.

4 (b) EXTENSION AND INCREASE IN PROGRAM.—Sec5 tion 1024(a) of the Act (21 U.S.C. 1524(a)) is amended—

6 (1) by striking ‘‘and’’ at the end of paragraph

7 (4);

8 (2) by striking the period at the end of para9 graph (5) and inserting a semicolon; and

10 (3) by adding at the end the following new

11 paragraphs:

12 ‘‘(6) $55,000,000 for fiscal year 2003;

13 ‘‘(7) $60,000,000 for fiscal year 2004;

14 ‘‘(8) $65,000,000 for fiscal year 2005; and

15 ‘‘(9) $70,000,000 for fiscal year 2006.’’.

16 (c) ADMINISTRATIVE COSTS.—Section 1024(b) of the

17 Act (21 U.S.C. 1524(b)) is amended by striking ‘‘amounts

18 authorized’’ and inserting ‘‘amounts made available’’.

19 (d) EXTENSION OF LIMITATION ON ADMINISTRATIVE

20 COSTS.—Section 1024(b) of the Act (21 U.S.C. 1524(b))

21 is amended by adding at the end the following new para22 graph:

23 ‘‘(6) 3 percent for each of fiscal years 2003

24 through 2006.’’.
3

•HR 5427 IH

1 (e) MODIFICATION OF AMOUNT FOR GRANT RENEW2 ALS.—Section 1032 of the Act (21 U.S.C. 1532) is

3 amended—

4 (1) by striking clause (iv) of subsection

5 (b)(1)(A) and inserting the following:

6 ‘‘(iv) LIMITATIONS.—

7 ‘‘(I) FUNDING LEVELS.—Except

8 as provided in subclause (II), the

9 amount of a grant award under this

10 subparagraph may not exceed

11 $100,000 for a fiscal year. In the sec12 ond year of the grant award period,

13 upon successful reapplication, a grant

14 recipient is eligible to maintain its

15 funding level at 100 percent of the

16 original award. In the third year of

17 the grant award period, upon success18 ful reapplication, a grant recipient is

19 eligible to maintain its funding level

20 at 75 percent of the original award.

21 In the fourth and fifth years of the

22 grant award period, upon successful

23 reapplication, a grant recipient is eli24 gible to maintain its funding level at

25 50 percent of the original award.
4

•HR 5427 IH

1 ‘‘(II) EXCEPTIONS.—Any grant

2 recipient receiving an award of

3 $50,000 or less is eligible in a subse4 quent fiscal year of the grant award

5 period, upon successful reapplication,

6 to receive not less than that amount.

7 A grant recipient receiving an award

8 amount greater than $50,000 and

9 successfully reapplying for a grant

10 award shall not have its funding level

11 reduced below $50,000 in any subse12 quent fiscal year of the grant award

13 period.’’; and

14 (2) by adding at the end the following new sub15 section:

16 ‘‘(c) MODIFICATION OF ELIGIBILITY CRITERIA.—The

17 Administrator may not implement any modification in the

18 criteria specified in subsection (a) for eligibility for the

19 renewal of a grant award under this section without con20 sulting the Advisory Commission.’’.

21 SEC. 2. REPORTING REQUIREMENTS.

22 (a) STUDY.—The Director of the Office of National

23 Drug Control Policy shall conduct a study that evaluates

24 the need, if any, to increase administrative costs for the
5

•HR 5427 IH

1 Drug-Free Communities Act (referred to in this section

2 as ‘‘the Act’’).

3 (b) REPORT.—After the completion of the study de4 scribed in subsection (a), but not later than 90 days after

5 the date of the enactment of this Act, the Director shall

6 submit to Congress a report that includes the findings of

7 such study and—

8 (1) information regarding current staffing levels

9 and administrative requirements necessary to carry

10 out the Act;

11 (2) the necessity, if any, and justification of an

12 increase in administrative funds, including the

13 amount of such increase, to carry out the Act;

14 (3) what programs or activities any proposed

15 increase will support and a description of how such

16 programs or activities will improve grant perform17 ance, application processing, grant administration,

18 and program support, including support for the Ad19 visory Commission established under the Act;

20 (4) a specific accounting of the amount or per21 centage of any such increase which will be used by

22 Federal agencies involved in administering or sup23 porting the program established under the Act; and

24 (5) an analysis of expected outcomes if adminis25 trative funds are increased and what measures the
6

•HR 5427 IH

1 Director and the Attorney General will take to limit

2 administrative costs in the future.

3 SEC. 3. ANTIDRUG COALITION INSTITUTE.

4 (a) IN GENERAL.—The Director of the Office of Na5 tional Drug Control Policy may make grants to an organi6 zation to provide for the establishment of a National Com7 munity Antidrug Coalition Institute.

8 (b) REQUIREMENTS.—The organization receiving a

9 grant under subsection (a) shall—

10 (1) be a national nonprofit organization that

11 represents, provides technical assistance and train12 ing to, and has special expertise and broad, national13 level experience in community antidrug coalitions;

14 and

15 (2) establish a National Community Antidrug

16 Coalition Institute that will—

17 (A) provide education, training, and tech18 nical assistance for coalition leaders and com19 munity teams;

20 (B) conduct research, testing, and diffu21 sion of tools, mechanisms, and measures to bet22 ter evaluate and document coalition perform23 ance measures and outcomes; and
7

•HR 5427 IH

1 (C) bridge the gap between research and

2 practice by translating knowledge from research

3 into practical information.

4 (c) AUTHORIZATION.—There are authorized to be ap5 propriated $2,000,000 for each of fiscal years 2002 and

6 2003 to make grants as provided in this section.

Æ